awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38151670-A3C50597-4E0D-46DC-9870-654B9B952059
Q38151670-A3C50597-4E0D-46DC-9870-654B9B952059
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38151670-A3C50597-4E0D-46DC-9870-654B9B952059
Molecular targeted therapy for hepatocellular carcinoma: current and future.
P2860
Q38151670-A3C50597-4E0D-46DC-9870-654B9B952059
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38151670-A3C50597-4E0D-46DC-9870-654B9B952059
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4fec2b38622216c530201a9ff67958c0bbf827ad
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.